Relation between Pisa syndrome and choline esterase inhibitors in a cohort of Alzheimer's disease patients;Syndrome de la tour de Pise : relation avec les inhibiteurs de l'acétylcholine estérase chez des patients âgés atteints de la maladie d'Alzheimer

Presse Medicale

Volumn 38, Issue 1, 2009, Pages 150-153

  Huvent Grelle, Dominique ^a   Roche, Jean ^a   Gaxatte, Cédric ^a   Dewailly, Philippe ^a   Puisieux, François ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; AMIODARONE; AMLODIPINE; CALCIPRAT; CALCIUM CARBONATE; CHOLINESTERASE INHIBITOR; CITALOPRAM; DONEPEZIL; ESOMEPRAZOLE; GALANTAMINE; INEXIUM; MEMANTINE; RISPERIDONE; RIVASTIGMINE; SPIRONOLACTONE; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; CASE REPORT; CLINICAL FEATURE; FEMALE; FLEXION CONTRACTURE; HUMAN; LETTER; MINI MENTAL STATE EXAMINATION; PISA SYNDROME; TREATMENT OUTCOME;

EID: 57949085150     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2008.08.007     Document Type: Letter

References (15)

1. Ekbom K., Lindholm H., and Ljungberg L. New dystonic syndrome associated with butyrophenone therapy. J Neurol 202 (1972) 94-103
2. Suzuki T., and Matsuzaka H. Drug-induced Pisa syndrome (pleurothotonus): epidemiology and management. CNS Drugs 16 (2002) 165-174
3. Yohanan M., Aulakh J.S., Weith J., and Haukins J. Pisa Syndrome in a patient in a wheelchair taking Valproïc Acid. Am J Psychiatry 163 (2006) 325-326
4. Duggal H.S., Sivamony S., and Umapathy C. Pisa Syndrome and atypical antipsychotics. Am J Psychiatry 161 (2004) 373-374
5. Kwak Y.T., Han I.I.W., Baik J., and Koo M.S. Relation between cholinesterase inhibitor and Pisa syndrome. Lancet 355 (2000) 2222
6. Vanacore N., Suzzareddu G., Maggini M., Casula A., Capelli P., and Raschetti R. Pisa Syndrome in a cohort of Alzheimer's disease patients. Acta neurol Scand 111 (2005) 199-201
7. Huvent-Grelle D., Roche J., Camus F.E., Dewailly P.H., and Puisieux F. Relation between cholinesterase inhibitors and Pisa syndrome in a cohort of five French patients with Alzheimer's disease. JAGS 55 (2007) 1472-1487
8. Khann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group. Neurology 34 (1984) 939-944
9. e édition. Traduction française par Guelfi JD. Masson (Paris) ; 1996.
10. Folstein M.F., Folstein S.E., and Mc Hugh P.R. Mini mental state, a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
11. Villarejo A., Camacho A., Garcia-Ramos R., Moreno T., Penas M., Juntas R., et al. Case report: Cholinergic-dopaminergic imbalance in Pisa syndrome. Clin Neuropharmacol 26 (2003) 119-121
12. Cossu G., Melis M., Melis G., Maccioni E., Putzu V., Catte O., et al. Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report. Mov Disord 19 (2004) 1243-1244
13. Miyaoka T., Seno H., Yamamori C., Inagaki T., Itoga M., Tsubouchi K., et al. Pisa syndrome due to a cholinesterase inhibitor (donepezil): a case report. J Clin Psychiatry 62 (2001) 573-574
14. Patel S.V., Tariot P.N., and Hamill R.W. Pisa syndrome without neuroleptic exposure in a patient with dementia of the Alzheimer type. J Geriatr Psychiatry Neurol 4 (1991) 48-51
15. Tariot P.N., Pendlebury W., and Hamilll R. Pisa syndrome without neuroleptic exposure in a patient with dementia of the Alzheimer type: a follow-up report. J Geriatr Psychiatry Neurol 10 (1997) 130